Janssen Funds New Global Leadership Initiative On Brain Health

Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced new funding for a global initiative to activate leaders from diverse backgrounds to transform society's approach to mental health. As the founding sponsor of The One Mind Initiative, Janssen has provided $1.1 million in funding with a goal of delivering better health and economic outcomes in brain health. Support for The One Mind Initiative is part of Janssen's global Healthy Minds program which encourages collaboration to accelerate new solutions for neurologic and brain diseases. The long-term mission of The One . . .